Customized research for ARPO vs. CNAT!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for ARPO vs. CNAT.


↗ Join Our Free Email Newsletter.




Aerpio Pharmaceuticals Inc. vs. Conatus Pharmaceuticals Inc.

Industry Match! Industry of Both ARPO and CNAT:

Health Care/Life Sciences

ARPO

Key Statistics

Cap: 133.917M


P/E: N/A

P/S: 11.6

Q P/B: 2.01

Y Rev: 11.54M

Q Rev: 18.82M

Beta: N/A

ARPO Share Stats

Outstanding Shares

40.6M

Float Shares

11.08M

Percent of Float Short

0.11%

ARPO Insider Stats

Percent Outstanding Insider Ownership

1.15%

Percent Outstanding Institution Ownership

30.18%

ARPO Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

ARPO in Pulse Portal

Stream of Posts

ARPO Symbol Page

Share ARPO Insights

Express Sentiment

'Buy' or 'Sell' ARPO

ARPO Profile

CEO

Mr. Muneer A. Satter

Exchange

Nasdaq

Employees

25.00

About

Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. Its lead program include a Tie2 activator for diabetic retinopathy and hypoxia-inducible factor. The company was founded by Joseph...

ARPO Financials

Annual Financials

Income Statement

Revenue

11.54M

Net Income

292.61%

Cash Flow Statement

Change in Cash / Investments

18.65M

Balance Sheet

Cash / Investments

20.26M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

20.9M

Total Current Liabilities

3.59M

Total Assets

21.03M

Total Liabilities

3.59M

Stockholder Equity

17.44M

Quarterly Financials

Income Statement

Q Revenue

18.82M

Q Net Income

11.54M

Cash Flow Statement

Q Change in Cash / Investments

24,057

Balance Sheet

Q Cash / Investments

68.81M

Q Short Term Debt

None

Q Long Term Debt

None

Q Total Current Assets

70.04M

Q Total Current Liabilities

3.64M

Q Total Assets

70.16M

Q Total Liabilities

3.64M

Q Stockholder Equity

66.52M

ARPO Charts

10-Year Chart

ARPO 10-Year Chart

5-Year Chart

ARPO 5-Year Chart

1-Year Chart

ARPO 1-Year Chart

6-Month Chart

ARPO 6-Month Chart

3-Month Chart

ARPO 3-Month Chart

1-Month Chart

ARPO 1-Month Chart

1-Day Chart

ARPO 1-Day Chart

CNAT

Key Statistics

Cap: 55.984M


P/E: N/A

P/S: N/A

Q P/B: 3.37

Y Rev: (4.59M)

Q Rev: 7.67M

Beta: 4.62

CNAT Share Stats

Outstanding Shares

33.14M

Float Shares

28.59M

Percent of Float Short

11.43%

CNAT Insider Stats

Percent Outstanding Insider Ownership

0.62%

Percent Outstanding Institution Ownership

38.34%

CNAT Social Stats

Followers

1

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

CNAT in Pulse Portal

Stream of Posts

CNAT Symbol Page

Share CNAT Insights

Express Sentiment

'Buy' or 'Sell' CNAT

CNAT Profile

CEO

Dr. Steven J. Mento

Exchange

Nasdaq

Employees

35.00

About

Conatus Pharmaceuticals, Inc. engages in the development and commercialization of medicines for the treatment of liver diseases. It focuses in development of emricasan, an active pan-caspase protease inhibitor for the treatment of patients with chronic liver disease,...

CNAT Financials

Annual Financials

Income Statement

Revenue

(4.59M)

Net Income

-2.05%

Cash Flow Statement

Change in Cash / Investments

(42M)

Balance Sheet

Cash / Investments

74.85M

Short Term Debt

None

Long Term Debt

13.16M

Total Current Assets

79.22M

Total Current Liabilities

28.14M

Total Assets

81.94M

Total Liabilities

53.94M

Stockholder Equity

28M

Quarterly Financials

Income Statement

Q Revenue

7.67M

Q Net Income

(4.59M)

Cash Flow Statement

Q Change in Cash / Investments

1.67M

Balance Sheet

Q Cash / Investments

49.62M

Q Short Term Debt

None

Q Long Term Debt

13.72M

Q Total Current Assets

56.9M

Q Total Current Liabilities

23.76M

Q Total Assets

58.14M

Q Total Liabilities

41.52M

Q Stockholder Equity

16.62M

CNAT Charts

10-Year Chart

CNAT 10-Year Chart

5-Year Chart

CNAT 5-Year Chart

1-Year Chart

CNAT 1-Year Chart

6-Month Chart

CNAT 6-Month Chart

3-Month Chart

CNAT 3-Month Chart

1-Month Chart

CNAT 1-Month Chart

1-Day Chart

CNAT 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon